FDA DEVICE FACTS
BRIGHTWAY BRAND NITRILE EXAMINATION GLOVES 12”, POWDER FREE, [STERLING/GREY] WITH CHEMOTHERAPY CLAIM
Brightway Holdings Sdn. Bhd.
FDA-sourced product information for medical-device development research. Use the official FDA sources at the end of this page when the original public document wording is needed.医療機器開発の調査用に、FDA の公開情報から取った製品情報を示しています。公開文書の原文が必要なときは、このページの最後にある FDA の公式な出典をご覧ください。
Indications for use
BRIGHTWAY BRAND NITR ILE EXAMINATION GLOVES 12”, POWDER FREE, [STERLING/GREY] WITH CHEMOTHERAPY CLAIM is a disposable device intended for medical purpose, to be worn on the examiners hand or finger to prevent contamination between patient and examiner.
The product has been tested with chemotherapy drugs in accordance with ASTM D6978. The breakthrough detection times are as follows:
Test Chemotherapy Drug Name and Concentration Minimum Breakthrough Detection Time Carmustine (BCNU) (3.3mg/ml),(3,300 ppm) 4.3 Minutes Cisplatin(1.0mg/ml), (1,000 ppm) >240 Minutes Cyclophosphamide/Cytoxan(20mg/ml), (20,000 ppm) >240 Minutes Dacarbazine(DTIC) 10mg/ml, (10,000 ppm) >240 Minutes Doxorubicin HCL(2mg/ml),(2,000 ppm) >240 Minutes Etoposide /Toposar (20mg/ml), (20,000 ppm) >240 Minutes Fluorouracil(50mg/ml), (50,000 ppm) >240 Minutes Ifosfamide (50mg/ml), (50,000 ppm) >240 Minutes Mitoxantrone(2mg/ml),(2,000 ppm) >240 Minutes Paclitaxel(6.0mg/ml),(6,000 ppm) >240 Minutes Thiotepa (10mg/ml),(10,000 ppm) 10.9 Minutes Vincristine Sulfate(1.0mg/ml),(1,000 ppm) >240 Minutes
Please note that Carmustine and Thiotepa have extremely low permeation times of 4.3 minutes and 10.9 minutes, respectively.
Warning: Do not use with Carmustine and Thiotepa.
Device description, AI/software, PCCP, evaluation and limitations are available with an account: seven days of full access after free registration, then with the paid plan.機器の説明、AI・ソフトウェア、PCCP、評価、制限事項は、アカウントでご覧いただけます。無料登録から 7 日間はすべて利用でき、その後は有料プランでご利用いただけます。
OFFICIAL FDA SOURCES
FDA Record and Public Document Status
Record and document link states are stored separately.FDA Record と公開文書のリンクの状態は、別々に記録しています。